Meridian Bioscience (VIVO) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $5.87 --0%
Financial Fact:
INCOME TAX PROVISION: 3.26M
Today's EPS Names:
MAYS, CRMT, REPL, More
Financial Fact:
INCOME TAX PROVISION: 3.26M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Meridian Bioscience (NASDAQ: VIVO) reported Q1 EPS of $0.24, in-line with the analyst estimate of $0.24. Revenue for the quarter came in at $51.55 million versus the consensus estimate of $50.5 million.
For earnings history and earnings-related data on Meridian Bioscience (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- FirstCash to acquire UK pawn operator Ramsdens for £206 million
- Stifel Starts Victrex Plc. (VCT:LN) (VTXPF) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
